Actionable news
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

Regeneron, Sanofi Score Eczema Drug Approval

U.S. regulators on Tuesday approved a new injectable drug from Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) to treat patients with eczema.

The FDA approval of Dupixent was widely expected so investors will now focus on the drug's commercial launch, where expectations are high. Analysts are forecasting peak sales as high as $5 billion per year.

Regeneron's shares fell slightly on the...